Bayer Expands Kerendia Program In Competitive Heart Failure Space

 
• By Alaric DeArment
  
Bayer is expanding its clinical trial program for Kerendia in heart failure • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D